In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE S - Sale D 642.9974 -1,130
2026-02-10 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP P - Purchase D 5.75 521,739
2026-02-10 IMDX / Insight Molecular Diagnostics Inc. 4 BROADWOOD PARTNERS LP Footnote P - Purchase I 0
2026-02-10 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE M - Exercise D 67.85 11,345
2026-02-09 IDXX / IDEXX Laboratories, Inc. 4 FENNELL GEORGE M - Exercise D 67.85 1,476
2026-02-02 NEOG / Neogen Corporation 4 Nassif Mikheal By son P - Purchase I 9.9997 24
2026-02-02 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard A - Award D 4,994
2026-02-02 MYGN / Myriad Genetics, Inc. 4 Verratti Mark A - Award D 32,810
2026-02-02 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale A - Award D 23,697
2026-02-02 MYGN / Myriad Genetics, Inc. 4 Haas Kevin Richard A - Award D 23,697
2026-02-01 VNRX / VolitionRx Limited 4 Plummer Nicholas F - Taxes D 0.285 -5,647
2026-02-01 VNRX / VolitionRx Limited 4 Rootsaert Rodney Gerard F - Taxes D 0.285 -3,196
2026-02-01 VNRX / VolitionRx Limited 4 Forterre Gael F - Taxes D 0.285 -2,010
2026-01-30 IDXX / IDEXX Laboratories, Inc. 4 HOOLEY JOSEPH L A - Award D 670.46 36
2026-01-26 NEOG / Neogen Corporation 4 Nassif Mikheal By son P - Purchase I 9.855 25
2026-01-22 VNRX / VolitionRx Limited 4 Colman Alan A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 Kway Jasmine A - Award D 42,000
2026-01-22 VNRX / VolitionRx Limited 4 Innes Guy Archibald A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 STILL TIMOTHY I A - Award D 90,000
2026-01-22 VNRX / VolitionRx Limited 4 Micallef Jacob Vincent A - Award D 35,400
2026-01-22 VNRX / VolitionRx Limited 4 Batchelor Ann-Louise A - Award D 33,900
2026-01-22 VNRX / VolitionRx Limited 4 Henshall Mickie A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 Forterre Gael A - Award D 38,100
2026-01-22 VNRX / VolitionRx Limited 4 Rubin Ethel A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 Plummer Nicholas A - Award D 44,700
2026-01-22 VNRX / VolitionRx Limited 4 Rootsaert Rodney Gerard A - Award D 28,200
2026-01-22 VNRX / VolitionRx Limited 4 Barnes Phillip A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 Hughes Terig A - Award D 49,200
2026-01-22 VNRX / VolitionRx Limited 4 Reynolds Cameron John A - Award D 74,700
2026-01-22 VNRX / VolitionRx Limited 4 Nguyen Kim A - Award D 12,000
2026-01-22 VNRX / VolitionRx Limited 4 Butera Salvatore Thomas A - Award D 53,400
2026-01-16 NEOG / Neogen Corporation 4 Nassif Mikheal By son P - Purchase I 9.3349 137
2026-01-16 QCLS / Q/C Technologies, Inc. 4 Voss Chelsea Sierra A - Award D 25,000
2026-01-16 QCLS / Q/C Technologies, Inc. 4 Voss Chelsea Sierra A - Award D 212,500
2026-01-07 NEOG / Neogen Corporation 4/A Ranalli Tamara A. A - Award D 7.38 50,813
2026-01-07 NEOG / Neogen Corporation 4/A Ranalli Tamara A. A - Award D 7.38 50,813
2026-01-07 NEOG / Neogen Corporation 4 Ranalli Tamara A. A - Award D 7.38 50,813
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. S - Sale D 9.21 -34,146
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Clark Eliana S - Sale D 9.21 -9,515
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Schultes Birgit C S - Sale D 9.21 -8,508
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Lebwohl David S - Sale D 9.21 -11,903
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Dube Michael P S - Sale D 9.21 -2,989
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Dulac Edward J III S - Sale D 9.21 -6,379
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 BASTA JAMES S - Sale D 9.21 -10,397
2026-01-05 NTLA / Intellia Therapeutics, Inc. 4 Cohen Fred E P - Purchase D 9.35 150,000
2026-01-02 CLDX / Celldex Therapeutics, Inc. 4 Martin Samuel Bates M - Exercise D 10.38 4,817
2026-01-01 MYGN / Myriad Genetics, Inc. 4 Muzzey Dale F - Taxes D 6.15 -418
2025-12-25 MYGN / Myriad Genetics, Inc. 4 Wheeler Benjamin Richard F - Taxes D 6.55 -21
2025-12-15 CLDX / Celldex Therapeutics, Inc. 4 PEPIN RONALD M - Exercise D 2.78 11,000
2025-12-15 CLDX / Celldex Therapeutics, Inc. 4 PEPIN RONALD M - Exercise D 9.0165 8,333
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)